Pharmaceutical Drug Targets and Diseases: Difference between revisions
David Canner (talk | contribs) No edit summary |
No edit summary |
||
| (19 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{#tree:id=siteTree| | {{#tree:id=siteTree| | ||
<big>The following is a list of major pharmaceutical compound targets, drugs, and information organized by disease. </big> | <big>The following is a list of major pharmaceutical compound targets, drugs, and information organized by disease. </big> | ||
| Line 10: | Line 9: | ||
**Anemia | **Anemia | ||
***[[Erythropoietin]] | ***[[Erythropoietin]] | ||
**Antifungal | |||
***[[Noxafil]] | |||
**Antimalarial | |||
***[[Malarial Dihydrofolate Reductase as Drug Target]] | |||
**Anti-parasitic | |||
***[[Ivermectin|Drug: Ivermectin; Target: Glutamate-gated chloride channels]] | |||
**Asthma and other Pulmonary Disease States | **Asthma and other Pulmonary Disease States | ||
***[[Beta-2 | ***[[Beta-2 Adrenergic Receptor]] | ||
***[[Leukotriene Receptor]] | ***[[Leukotriene Receptor]] | ||
| Line 20: | Line 28: | ||
**Autoimmune Diseases | **Autoimmune Diseases | ||
***[[Tumor | ***[[Prolyl Endopeptidase]] | ||
***[[Tumor necrosis factor receptor]] | |||
***[[Molecular_Playground/TRAIL|Tumor-Necrosis Factor Apoptosis-Inducing Ligand]] | ***[[Molecular_Playground/TRAIL|Tumor-Necrosis Factor Apoptosis-Inducing Ligand]] | ||
**Bacterial Infections | **Bacterial Infections | ||
*** See: [[Bacterial Infections]] | *** See: [[Bacterial Infections]] | ||
***[[Treatment of Tuberculosis]] | |||
**Blood Clots, Haemophilia, & Thrombic Events | **Blood Clots, Haemophilia, & Thrombic Events | ||
| Line 30: | Line 40: | ||
***Haemophilia | ***Haemophilia | ||
**** See: [[Hemophilia]] | **** See: [[Hemophilia]] | ||
***[[Platelet-receptor glycoprotein Ib alpha]] | |||
**Cancer | **Cancer | ||
| Line 45: | Line 56: | ||
**Digestive Diseases | **Digestive Diseases | ||
***[[ | ***Proton Pump | ||
****[[Esomeprazole and H+/K+ - ATPase Interaction]] | |||
**Erectile Dysfunction | **Erectile Dysfunction | ||
| Line 51: | Line 63: | ||
**Hypertension & Congestive Heart Failure | **Hypertension & Congestive Heart Failure | ||
***[[ | ***See: [[Hypertension & Congestive Heart Failure]] | ||
**Inflammation & Rheumatoid Arthritis | **Inflammation & Rheumatoid Arthritis | ||
***[[ | ***[[Inflammation & Rheumatoid Arthritis]] | ||
**Metabolic Disorders | **Metabolic Disorders | ||
*** See: [[Metabolic Disorders]] | *** See: [[Metabolic Disorders]] | ||
**Schizophrenia, Bipolar Depression, Insomnia, and Anxiety Disorders | **Schizophrenia, Bipolar Depression, Depression, Insomnia, and Anxiety Disorders | ||
***[[Dopamine | ***[[Dopamine receptor]] | ||
***[[ | ***[[Adrenergic receptor]] | ||
***[[Histamine | ***[[Histamine H1 receptor]] | ||
***[[Opioid | ***[[Opioid receptor]] | ||
***[[5-hydroxytryptamine receptor]] | |||
**Viral Infection | **Viral Infection | ||
| Line 77: | Line 86: | ||
*** [[Herpes Simplex Virus Thymidine Kinase]] | *** [[Herpes Simplex Virus Thymidine Kinase]] | ||
*** [[NS5B|RNA Dependent RNA Polymerase from Hepatitis C Virus]] | *** [[NS5B|RNA Dependent RNA Polymerase from Hepatitis C Virus]] | ||
*** Poliovirus | |||
****[[Journal:PLoS ONE:1|Antiviral Activity of 3(2H)- and 6-Chloro-3(2H)-Isoflavenes against Highly Diverged, Neurovirulent Vaccine-Derived, Type2 Poliovirus Sewage Isolates]] | |||
*** [[Interferon]] | |||
}} | }} | ||
See [[Pharmaceutical Drugs]] for descriptions and analysis of well known drugs | |||